Dr. Roxana Mehran has been appointed as the new president of the American College of Cardiology (ACC), embarking on a pivotal one-year term leading one of the world’s foremost organizations dedicated to cardiovascular medicine. The ACC, boasting nearly 60,000 members worldwide, is committed to revolutionizing cardiovascular care and enhancing heart health globally. Dr. Mehran’s presidency marks a continuation of the College’s mission to integrate scientific innovation and clinical practice to improve outcomes for patients with cardiovascular diseases.
A renowned figure in interventional cardiology and cardiovascular research, Dr. Mehran brings a wealth of experience and a global perspective to her leadership role. Holding an endowed professorship in cardiovascular clinical research and outcomes at the Icahn School of Medicine at Mount Sinai, she also serves as the director of the Women’s Heart and Vascular Center. This multidisciplinary center focuses on the unique cardiovascular needs of women, a population that has historically been underrepresented in cardiovascular research and care protocols. Dr. Mehran’s clinical and academic roles emphasize her commitment to precision medicine tailored to diverse patient populations.
Her leadership at the ACC underscores a strategic focus on expanding global partnerships and fostering member engagement to drive innovation and professional growth. The College, through initiatives such as the National Cardiovascular Data Registry (NCDR) and its suite of JACC journals, has established itself as an authoritative source of evidence-based guidelines and cardiovascular education worldwide. Under her guidance, the ACC aims to deepen collaborations across borders to tackle cardiovascular disease more effectively on a global scale.
Dr. Mehran’s scientific contributions are prolific and impactful. She has led multiple landmark clinical trials and global studies that have shaped contemporary interventional cardiology practices. Her research has addressed critical aspects of cardiovascular disease management, including novel stent technologies, antithrombotic therapies, and risk stratification models. These efforts have increasingly been focused on stratifying therapy to optimize outcomes and reduce procedural complications especially among high-risk patient cohorts.
Particularly notable is her advocacy for elevating women’s roles in medicine, both as practitioners and as patients underserved by traditional cardiovascular paradigms. As the founder and chief scientific officer of the Cardiovascular Research Foundation and the founder of Women as One—a nonprofit dedicated to advancing women in cardiology—Dr. Mehran actively promotes gender equity in academic medicine and clinical research leadership. This dual commitment enhances the ACC’s efforts to address disparities in cardiovascular health and professional development within the field.
Her extensive publication record, with thousands of peer-reviewed articles and guideline contributions, illustrates a deep engagement with evidence synthesis and dissemination. Being recognized by Clarivate Analytics as one of the world’s most highly cited scientific minds for eight consecutive years speaks to the seminal influence of Dr. Mehran’s findings in advancing cardiology knowledge and clinical practice.
Throughout her tenure in the ACC prior to her presidency, Dr. Mehran held substantive leadership roles including chairing the Interventional Section Leadership Council and serving on the Board of Trustees. Her involvement has been crucial to shaping the College’s strategic direction and clinical guideline development, aligning expert consensus with real-world practice needs. Dr. Mehran’s leadership style is characterized by a collaborative approach, leveraging diverse expertise to foster innovation and inclusivity.
Her accolades reflect a career distinguished by medical leadership and scientific excellence. Among the numerous awards are the ACC’s Bernadine Healy Leadership in Cardiovascular Disease Award and the Nanette Wenger Award for Excellence in Medical Leadership from WomenHeart. International recognition includes the Ellis Island Medal of Honor and the European Society of Cardiology Silver Medal, highlighting her global impact on cardiovascular medicine.
The transition to Dr. Mehran’s presidency will be formally enacted during the Convocation Ceremony of the ACC’s Annual Scientific Session in New Orleans, scheduled for March 28-30, 2026. This event will also usher in new officers who will collaborate to steer the global cardiovascular community toward enhanced education, research, and patient care initiatives.
Dr. Mehran’s presidency promises to invigorate the ACC’s commitment to fostering scientific rigor and compassionate care. As cardiovascular disease remains the leading cause of mortality worldwide, the College’s efforts under her leadership to integrate cutting-edge research with clinical application are timely and essential. The evolving landscape of cardiovascular medicine, including advances in molecular cardiology, precision imaging, and digital health, will likely be areas of focus and growth during her term.
The ACC continues to be a beacon of innovation, education, and advocacy in cardiovascular medicine. Dr. Roxana Mehran’s stewardship exemplifies the intersection of clinical excellence, research leadership, and commitment to equity, positioning the College to make transformative strides in understanding and combating cardiovascular diseases globally.
Subject of Research: Cardiovascular medicine, interventional cardiology, women’s cardiovascular health, clinical guidelines development
Article Title: Dr. Roxana Mehran Assumes Presidency of the American College of Cardiology: A New Era in Global Cardiovascular Leadership
News Publication Date: Not specified (anticipated 2026)
Web References: American College of Cardiology
Image Credits: American College of Cardiology
Keywords: Roxana Mehran, American College of Cardiology, cardiovascular care, interventional cardiology, Women’s Heart and Vascular Center, cardiovascular research, clinical guidelines, cardiovascular disease prevention, Women as One, global cardiovascular partnerships
